Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PERFECT: Delay and Antibiotics in Acute Appendicitis
NCT04378868Phase 4Completed
- Sponsor
- Helsinki University Hospital
- Start
- May 2020
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of cefuroxime and metronidazole in appendicitis (4 arms), sponsored by Helsinki University Hospital. Primary endpoint: Complicated appendicitis. Started May 2020; status: completed.
02
Drugs
cefuroximemetronidazole
03
Conditions
appendicitis
Beyond the preview
Go deeper on NCT04378868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04378868.